Depression and the Brain

Encyclopedia of Neuroscience

Volumn , Issue , 2009, Pages 459-470

  Drevets, W C ^a   Furey, M L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84880073904     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008045046-9.00846-9     Document Type: Chapter

References (28)

1. Austin M.P., Mitchell P., Goodwin G.M. Cognitive deficits in depression: Possible implications for functional neuropathology. British Journal of Psychiatry 2001, 178:200-206.
2. Carney R.M., Freedland K.E., Veith R.C. Depression, the autonomic nervous system, and coronary heart disease. Psychosomatic Medicine 2005, 67(supplement 1):S29-S33.
3. Davis M., Shi C. The extended amygdala: Are the central nucleus of the amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety?. Annals of the New York Academy of Sciences 1999, 877:281-291.
4. Detera-Wadleigh S.D., McMahon F.J. Genetic association studies in mood disorders: Issues and promise. International Review of Psychiatry 2004, 16(4):301-310.
5. Drevets W.C., Price J.L. Neuroimaging and neuropathological studies of mood disorders. Biology of Depression: From Novel Insights to Therapeutic Strategies 2005, 427-466. Wiley-VCH Verlag GmbH & Co, Weinheim. W.M. Licinio, M.-L. Wong (Eds.).
6. Drevets W.C., Todd R.D. Depression, mania and related disorders. Adult Psychiatry 2005, 91-129. Blackwell Publishing, Oxford. 2nd edn. E. Rubin, C. Zorumski (Eds.).
7. Everitt B.J., Robbins T.W. Central cholinergic systems and cognition. Annual Review of Psychology 1997, 48:649-684.
8. Furey M.L., Drevets W.C. Antidepressant efficacy of the antimuscarinic drug scopolamine: A randomized, placebo-controlled clinical trial. Archives General Psychiatry 2006, 63(10):1121-1129.
9. Furey M.L., Pietrini P., Haxby J.V. Cholinergic enhancement and increased selectivity of perceptual processing during working memory. Science 2000, 290(5500):2315-2319.
10. Gold P.W., Drevets W.C., Charney D.S. New insights into the role of cortisol and the glucocorticoid receptor in severe depression. Biological Psychiatry 2002, 52(5):381-385.
11. Goto Y., Grace A.A. Dopaminergic modulation of limbic and cortical drive of nucleus accumbens in goal-directed behavior. Nature Neuroscience 2005, 8(6):805-812.
12. Herman J.P., Cullinan W.E. Neurocircuitry of stress: Central control of the hypothalamo-pituitary-adrenocortical axis. Trends in Neurosciences 1997, 20(2):78-84.
13. Izquierdo A., Wellman C.L., Holmes A. Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. Journal of Neuroscience 2006, 26(21):5733-5738.
14. Janowsky D.S., Overstreet D.H. The Role of Acetylcholine Mechanisms in Mood Disorders 1995, Raven Press, New York.
15. Krystal J.H., Sanacora G., Blumberg H., et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Molecular Psychiatry 2002, 7(supplement 1):S71-S80.
16. LeDoux J. The emotional brain, fear, and the amygdala. Cellular and Molecular Neurobiology 2003, 23(4-5):727-738.
17. López J.F., Chalmers D.T., Little K.Y., et al. A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: Implications for the neurobiology of depression. Biological Psychiatry 1998, 43(8):547-573.
18. Manji H.K., Drevets W.C., Charney D. The cellular neurobiology of depression. Nature Medicine 2001, 7(5):541-547.
19. Mayberg H.S., Lozano A.M., Kennedy S.H., et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005, 45(5):651-660.
20. McEwen B.S., Magarinos A.M. Stress and hippocampal plasticity: Implications for the pathophysiology of affective disorders. Human Psychopharmacology 2001, 16(S1):S7-S19.
21. Nestler E.J., Carlezon W.A. The mesolimbic dopamine reward circuit in depression. Biological Psychiatry 2006, 59(12):1151-1159.
22. Ottowitz W.E., Dougherty D.D., Savage C.R. The neural network basis for abnormalities of attention and executive function in major depressive disorder: Implications for application of the medical disease model to psychiatric disorders. Harvard Review of Psychiatry 2002, 10(2):86-99.
23. Phillips M.L., Drevets W.C., Rauch S.L., et al. Neurobiology of emotion perception II: Implications for major psychiatric disorders. Biological Psychiatry 2003, 54(5):515-528.
24. Sarter M., Nelson C.L., Bruno J.P. Cortical cholinergic transmission and cortical information processing in schizophrenia. Schizophrenia Bulletin 2005, 31(1):117-138.
25. Stockmeier C.A. Involvement of serotonin in depression: Evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. Journal of Psychiatric Research 2003, 37(5):357-373.
26. Sullivan P.F., Neale M.C., Kendler K.S. Genetic epidemiology of major depression: Review and meta-analysis. American Journal of Psychiatry 2000, 157(10):1552-1562.
27. Swaab D.F., Bao A.M., Lucassen P.J. The stress system in the human brain in depression and neurodegeneration. Ageing Research Review 2005, 4(2):141-194.
28. Tavares J.V., Drevets W.C., Sahakian B.J. Cognition in mania and depression. Psychological Medicine 2003, 33(6):959-967.